Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Identification and treatment of
abdominal aortic aneurysm
(
AAA
) remain among the most prominent challenges in vascular medicine. MicroRNAs (miRNAs) are crucial regulators of cardiovascular pathology and represent intriguing targets to limit
AAA
expansion. Here we show, by using two established murine models of
AAA
disease along with human aortic tissue and plasma analysis, that miR-24 is a key regulator of vascular inflammation and
AAA
pathology. In vivo and in vitro studies reveal chitinase 3-like 1 (Chi3l1) to be a major target and effector under the control of miR-24, regulating cytokine synthesis in macrophages as well as their survival, promoting aortic smooth muscle cell migration and cytokine production, and stimulating adhesion molecule expression in vascular endothelial cells. We further show that modulation of miR-24 alters
AAA
progression in animal models, and that miR-24 and
CHI3L1
represent novel plasma biomarkers of
AAA
disease progression in humans.
...
PMID:miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. 2571 53